Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence
Neoangiogenesis is mediated by circulating bone marrow-derived endothelial progenitors (circulating EPCs). The aim of the study was the quantification of circulating EPCs from the peripheral blood mononuclear cells of invasive breast cancer (IBrC) patients by flow cytometry, before and after cancer...
Main Authors: | Piotr Rhone, Kornel Bielawski, Katarzyna Ziołkowska, Danuta Rość, Barbara Ruszkowska-Ciastek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/11/1984 |
Similar Items
-
Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Microparticles in Cancer
by: P.K.Y. Goon, et al.
Published: (2006-02-01) -
Stromal Cell-Derived Factor 1α (SDF-1α) in Invasive Breast Cancer: Associations with Vasculo-Angiogenic Factors and Prognostic Significance
by: Elżbieta Zarychta, et al.
Published: (2021-04-01) -
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
by: Kuo Yu-Hsuan, et al.
Published: (2012-12-01) -
Increased number of endothelial progenitor cells in the blood of patients with psoriasis vulgaris
by: Justyna Małkowska, et al.
Published: (2021-05-01) -
Levels and values of circulating endothelial progenitor cells, soluble angiogenic factors, and mononuclear cell apoptosis in liver cirrhosis patients
by: Chen Chih-Hung, et al.
Published: (2012-07-01)